Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.38 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.38 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.38 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.32 |
| ▸ | ADORA2B | P29275 | 9/20 | 0.31 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23309542 | 0.84 | CA12 (0.42) | KMT2A | |
| SCHEMBL23309619 | 0.76 | NPC1 (0.40) | — | |
| SCHEMBL23309663 | 0.75 | ALDH1A1 (0.50) | KMT2A | |
| SCHEMBL23309560 | 0.73 | PLAT (0.37) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL23309580 | 0.72 | KLKB1 (0.41) | KLKB1 | |
| SCHEMBL23309544 | 0.72 | TSHR (0.48) | KMT2A | |
| SCHEMBL23309630 | 0.71 | PLAT (0.39) | — | |
| SCHEMBL23309579 | 0.70 | ALDH1A1 (0.49) | — | |
| SCHEMBL25954742 | 0.69 | KIF11 (0.40) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL3387152 | 0.68 | KEAP1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210120817-A1 | PLANT DISEASE CONTROL AGENT | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2021-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210120817-A1 | PLANT DISEASE CONTROL AGENT | BROX, ALG1, CTRL | GABRA1 3807/4885GABRG2 4026/4885GABRB3 4584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.